Streptococcus suis is a major zoonotic pathogen that causes severe disease in both humans and pigs. 22
Introduction 47
Streptococcus suis is an agent of serious concern for the global swine industry, and an emerging 48 zoonotic agent causing meningitis, sepsis, arthritis, endocarditis and endopthalmitis in humans. 49
Human disease is particularly prevalent in the western Pacific and south-east Asian regions, where 50 risk is predominantly attributable to poor sanitation at slaughter and ingestion of undercooked pork, 51 followed by Europe and then significantly less in the Americas (1) . Zoonotic infection with S. suis has 52 occurred in Australia, although there are few reports in the literature. The most recently published 53 cases occurred in 2007 and 2008 in an abattoir worker from Victoria and two piggery workers from 54 New South Wales respectively (2, 3) with each case attributed to serotype 2, which, along with 55 serotype 14, is one of two globally-dominant serotypes detected in human cases. 56
In swine, S. suis is predominantly carried on the tonsils, but also within nasal cavities, genital and 57 gastrointestinal tracts of many clinically healthy pigs, a feature which complicates management 58 strategies in herds with disease outbreaks. Despite this carriage in healthy pigs, S suis is a cause of a 59 wide range of clinical syndromes ranging from sudden death in the peracute manifestation of 60 disease, to meningitis, septicaemia, endocarditis, arthritis and pneumonia. The clinical 61 manifestations generally occur in the post-weaning period, although can occur less frequently in 62 suckers and in adult pigs (4). Isolates obtained from areas indicative of invasive disease such as 63 joints, brain tissue, heart and abdomen may be referred to as systemic, or causative of systemic 64 infection, in contrast to isolates obtained from lung tissue. 65
Treatment for affected animals is usually reliant on administration of β-lactams such as penicillin and 66 amoxicillin, and, where permitted, farms may prophylactically treat all pigs at the peri-weaning 67 stage. Another management option employed by some producers is vaccination, usually in the form 68 of bacterins produced as autogenous vaccines from on-farm isolates (5). Due to the highly variable 69 antigenicity of the capsular polysaccharides (CPS), S. suis is currently classified into 29 serotypes (six 70 previously classified serotypes have been reassigned to different bacterial species) (6), and it is 71 considered that protection (if any) is only provided by homologous vaccine serotypes. In addition to 72 4 this, virulence factors and yet to be determined genetic factors may play a role in poor vaccine 73 efficacy (7), although virulence factors are not necessarily protective antigens and the current 74 uncertainty surrounding the role of virulence factors makes this difficult to assess. 75 A recent review on the worldwide distribution and typing of S. suis by Goyette-Desjardins et al. 76 (2014) provided a comprehensive analysis of the predominant serotypes and MLSTs in swine 77 production systems across the US, South America, Europe and South-East Asia (8). Of note in this 78 review was the lack of information on Australian S. suis types, with no published surveillance since 79 1994 (9) , a gap of 20 years. Following this a study published in 2015 on 45 Australian S. suis isolates 80 (encompassing 3 human isolates from 2006-2008, and 42 swine isolates from 1981-2011) described 81 4 MLST's (1, 25, 369 and 28) (10) . 82
Given the paucity of data available on S. suis associated with disease in Australian pigs, the aim of 83 this study was to analyse and characterise a significant number of S. suis isolates from diseased pigs 84 obtained across multiple production sites and spanning a seven year period. In addition to serotype 85 and MLST, we report on virulence factors and antimicrobial susceptibility, and compare the core 86 genome to international isolates to assess evolution in a global context. 87
88

Results
89
Samples 90 A total of 148 swabs from archived clinical isolates were transferred from ACE Laboratory Services (a 91 major swine-industry referral lab) to the Murdoch University Antimicrobial Resistance and Infectious 92
Diseases Laboratory for detailed molecular analysis. The majority of isolates were acquired from the 93 lungs of diseased pigs and were classified as potentially virulent, followed by isolates from heart, 94 brain, abdomen and joints which were classified as virulent isolates, and miscellaneous sites 95 including upper respiratory tract, abscesses and lymphoid tissue ( Table 1) . Isolates spanned a seven 96
year period with 2, 1, 29, 27, 9, 49 and 29 isolates from years 2010, 2011, 2013, 2014, 2015, 2016 97 and 2017 respectively, and two isolates for which the year was unknown. Isolates were originally 98 5 obtained from at least 10 of Australia's major pig production enterprises (17 samples were of 99 unknown origin) and encompassed 46 known individual farms (7 isolates had unavailable farm data). 100
Of the available farm data, 39 farms accounted for between one and five isolates each, five farms 101 accounted for between six and eight isolates each and one farm accounted for 33 isolates. 102 MLSTs assigned as a result of this study were ST 1031 -ST 1056 inclusive. 111 and serotype 3 (37/148). The other main serotypes were 1/2 (11/148), 16 (8/148), 19 (8/148), 8 113 (7/148) and 4 (7/148). Analysis of serotypes and MLST combined showed a high proportion of 114 isolates as serotype 2 ST25 (17.6%), serotype 2 ST28 (6.1%) and serotype 3 ST27 (18.2%). Of 115 serotypes where more than one isolate was present, serotype 15 (n=2), 16 (n=8), 21 (n=4) and 31 116 (n=5) all had previously unidentified STs. 117
The proportion of isolates carrying the main virulence factors mrp, epf or sly across all isolates was 118 7.4% (cps 1/2, 2, 14 and 19), 6.8% (cps 1/2, 2 and 14) and 33. 1% (caps1/2, 2, 3, 4, 5, 7, 8, 11, 12, 14, 119 15, 16, 18, 19, 21, and 23) respectively. Only a single isolate carried both mrp and sly, while 6.8% of 120 isolates carried both mrp and epf, and 6.8% carried mrp, epf and sly. The isolates carrying all three 121 genes belonged to serotypes 1/2 (n=7), 2 (n=2) and 14 and all belonged to MLST 1, indicating a 122 significant association between ST 1 and the carriage of all three genes (Fisher's exact test P-value 123 <0.0001). Although predominantly isolated from lung, two of these isolates originated from brain 124 and two from joint fluid and all four of these isolates were serotype 1/2. These serotype 1/2 ST1 125 isolates also carried more virulence genes with an average of 46 compared to all other isolates 126 carrying 36 virulence genes and were clustered in virulence gene group 2 (Figure 1 ). 127
The main putative virulence genes present across all isolates included enolase (100%), GAPDH 128 (100%), gdh (100%), luxS (100%), pgdA (100%), stk (100%), divIVA (99.3%), dltA (99.3%), dnaJ 129 7 dppIV, epf, mrp, sbp2, oppA and lde. This group consists predominantly of serotype 1/2 and serotype 137 2 isolates, and all are ST1. Groups 3 and 4 are similar in gene composition with the exception that 138 group 3 isolates are lacking a combination of fba, gidA, ciaR and hylA, and group 4 isolates have a 139 combination of iga, sly and in some cases fbps and dnaK. However group 3 isolates have a 140 combination of iga, sly and Tran which is not present in Group 4. 141 On average, the total gene content of systemic isolates from brain and joint, was 2057, significantly 150 lower than that from respiratory isolates which carried 2109 (Mann-Whitney U test p-value = 0.025). 151
When isolates from brain, joint, heart and abdomen were analysed, the average total gene content 152 was 2095, which was not significantly different from respiratory isolates (p-value=0.682). When the 153 total gene content of isolates was compared to the number of virulence genes a trend was observed 154 based upon ST (Figure 2a ). This was most apparent in the ST1 isolates which had a significantly 155 higher number of virulence genes compared to the other ST's, and the lowest number of total genes 156 with an average total gene content of 1918 (p-value<0.00001). ST25 isolates also formed a tight 157 cluster with a mean of 35.7 virulence genes and a relatively low total mean gene content of 2050. 158
Despite having a mean virulence gene content of 36, ST28 isolates clustered with some of the 159 highest total gene contents with all isolates having greater than 2100 genes and 9/11 having greater 160 8 than 2200 genes. These findings were mirrored by an assessment of global S. suis virulence genes 161 against total gene content ( Figure 2b ). Most striking is the consistent clustering of ST1 isolates with a 162 mean virulence gene content of 45.8 and a mean gene content of 1936. The six non-ST1 isolates 163 within this cluster consist of ST107 (n=1), ST105 (n=2) and ST144 (n=3) which are single locus 164 variants (SLV) of ST1 at the dpr, gki and cpn60 loci respectively. Additionally, for the published 165 systemic isolates from Weinert et al. (2015) , from which data was analysed and MLST able to be 166 determined using our pipeline, 51/108 (47.2%) were ST1, with the next highest proportion being 167 ST28 at 17/108. When SLVs were analysed, another seven isolates were found to be variants at the 168 gki locus, such that when ST1 and ST1 SLV isolates were combined they accounted for 53.7% of 169 systemic isolates. 170 All 148 isolates were subjected to micro-broth dilution to determine the MIC value against ten 197 antibiotics belonging to eight classes ( 
203 (Table 3) . Commonly identified MDR phenotypes included 208 macrolide/phenicol/tetracycline (7.4%) and β-lactam/macrolide/tetracycline (6.1%). All isolates 209 carried resistance against at least one antimicrobial class with 73.7% resistant to two classes of 210 antimicrobial classes (2). The most common phenotypic profile was resistance to a combination of 211 macrolides and tetracyclines with 67.6% of isolates determined to carry this resistance. When 212 analysed by clonal type or serotype there was no discernible pattern in AMR phenotype. 213
The two dominant antimicrobial resistance genes detected in these isolates were tetO and ermB. 214
The percentage of isolates carrying identified resistance genes for tetracyclines (95.3%) and 215 macrolides (80.5%) support the MIC data with 96.3% and 83.8% of isolates being resistant to 216 tetracyclines and macrolides respectively. Other resistant genes present included aph (3' Streptococcus suis is a major cause of disease in pigs, with the potential for significant public health 226 impact. Along with antimicrobial therapy, control measures in swine herds rely on the production of 227 autogenous vaccines, with variable, and often poor, success rates (7, 11) . Given the range of 228 serotypes and STs, in conjunction with proven and putative virulence factors and markers, choosing 229 appropriate clones for vaccine stock is difficult, and reliant on having adequate data. In this study we 230 present a detailed assessment of S.suis isolates from clinically affected Australian pigs, and compare 231 these isolates to internationally available genome sequence data. Key findings include the virulence 232 potential of ST1 clones, the zoonotic disease potential of Australian ST1 clones which cluster with 233
Vietnamese isolates from cases of human disease, and the limited evolution of Australian clones 234 from their global seed strains. 235
Analysis of 148 Australian isolates determined that the majority were serotype 2 (26%) or serotype 3 236 (25%), followed by serotype 1/2 (7.4%). This is consistent with global S. suis strains isolated from 237 cases of disease, particularly for serotypes 2 and 3 in Canada, North America and China (8). While 238 the majority of isolates were obtained from lungs, 32 isolates were obtained from brain, abdomen, 239 heart or joint, suggesting invasive or systemic isolates. Of these, 13 were serotype 2 and six were 240 serotype 1/2, however given this relatively small sample size of systemic isolates, an increased 241 pathogenicity cannot necessarily be ascribed to these serotypes. Significantly, even within this 242 sample set, there were 20 individual serotypes detected (Supplementary Table 1 ). Given that the 243 capsule is a recognised virulence factor and an immunogenic target (12), a minimum requirement 244 for vaccine production should be serotyping from an outbreak strain. 245 new MLSTs. This greatly expands upon previously available Australian data which documented four 247 STs including 1, 25, 28 and 369 (10) . The prevalence of isolates as serotype 2 ST25 (17.6%) and 248 serotype 2 ST28 (6.1%) is consistent with those from North America, Canada, Germany, Spain, the 249 United Kingdom and China, and serotype 3 ST27 (18.2%) is consistent with reports from Spain and 250 the United Kingdom (8). These findings indicate that capsular and ST combinations are stable and 251 conserved, and it is likely that the circulating strains present in Australia are reflective of the seed 252 stock which was imported from the United Kingdom, Canada and New Zealand (13). 253
Despite conservation of serotype/ST combinations, the use of whole genome sequencing 254 demonstrates geographic clustering at the level of the core genome. Analysis of Australian and 255 international isolates demonstrates four clades, although more than 80% of the isolates are present 256 in clades 2 and 4. Clade 2 consists of isolates from the United Kingdom, Canada and Australia. It can 257 be seen that the Australian isolates form distinct clusters, which correlate with serotype/MLST 258 combinations. The most interesting and distinct cluster was seen in Clade 2, whereby Australian 259 serotype 2 ST25 isolates (Fig 4 red) clustered within Canadian serotype 2 ST25 isolates (Fig 4 yellow) . 260
Further analysis by re-deriving the core genome for only these isolates showed two distinct 261 populations separated according to geographic origin. This further supports the hypothesis that 262 serotype/ST combinations are stable, however once introduced into a region these will then form 263 divergent populations which over time become phylogenetically distinct from the original clone. 264
Only eight Australian isolates were present in clade 4, which otherwise consisted entirely of 265 Vietnamese and UK isolates. These Australian isolates were all serotype 1/2 ST1: aside from a single 266 isolate which was serotype 14 ST1. This appears to indicate that the MLST of S. suis is a better 267 predictor of core genome phylogeny than the serotype. The presence of these isolates and their core 268 genome similarity to the south-east Asian isolates could be due to two reasons. Historically, assays 269 did not differentiate between serotypes 2 and 1/2, with isolates being reported as serotype 2 or 270 serotype 2 (plus 1/2) (14) . For this reason it may be that these isolates are derived from European 271 normal swine worker from south-east Asia transmitted a precursor serotype 1/2 clone from the 273 Asian region to Australian pigs. It is difficult to assess the likelihood of this pathway however, given 274 that most human S. suis documentation refers to clinically affected humans, clinically affected 275 humans have not been documented to infect other people or pigs, and that the epidemiology and 276 carriage in clinically unaffected humans is not well defined (15) . 277
There are an increasing number of virulence factors termed critical to virulent strains of S. suis, 278 which arguably are not critical but in various combinations may affect the virulence of different 279 clones (16). Historically there has been a focus on three particular virulence factors; muraminidase-280 released protein (mrp), extracellular protein factor (epf) and suilysin (sly), shown to be associated 281 with highly virulent strains, with cps2 strains carrying all three genes considered the most virulent 282 globally (17). Analysis of Australian isolates revealed that serotype 2 and 3 isolates were almost 283 exclusively mrp -/epf -/sly -. This is in agreement with early studies demonstrating that the presence of 284 all three of these factors is not necessary for a clone to exhibit high levels of virulence (18), with 285 9/18 (50%) of the isolates obtained from joints or brain having this gene combination. The presence 286 of the mrp + /epf + /sly + combination in 7/11 (63.6%) of serotype 1/2 isolates, along with 4/7 of these 287 isolates being from joints or brain, indicates that Australian serotype 1/2 isolates have particular 288 virulence potential, in contrast to earlier studies which concluded clinical disease in Canadian pigs 289 with serotype 1/2 was likely due to inherent herd factors (19) . It was notable that serotype 1/2 290 isolates were obtained from six separate farms and six separate production enterprises, indicating 291 that this serotype is not confined to a single company or nucleus herd. The mrp + /epf + /sly + 292 combination was also carried by all ST1 isolates, and these were consistently the isolates with the 293 largest array of putative virulence factors. Like serotype 1/2 isolates, ST1 isolates were obtained 294 from six farms and production enterprises, indicating this is a widespread, potentially virulent clone. 295 seen in Figure 2 , providing further evidence that MLST is a significant indicator of clonal virulence 297 potential when investigating a disease outbreak. In the case of Australian ST1 isolates, a conserved 298 constellation of virulence genes which was not present in other MLSTs provides some insight into 299 the virulence of ST1 clones. While the majority of these genes have their potential virulence 300 characteristics defined in vitro, there is a distinct aggregation of bacterial adhesion factors such as 301 fibronectin binding factors dpp IV, mrp, epf and sbp2 and oligopeptide binding protein oppA (20-23). 302
The presence of ide, an IgM protease would also be involved in early phase infection and attachment 303 to cells by cleaving IgM blocking cellular binding factors (24). 304
When this gene block was investigated in ST1 clones from overseas, it was also found to be highly 305 conserved across 226 isolates, with the exception of the oppA gene which was absent in 21.2% of 306 isolates. Taken together these factors suggest that both Australian and international ST1 clones have 307 a distinct fitness advantage in terms of binding ability towards host target cells. In order to 308 determine if the potential virulence of Australian ST1 isolates could be classified by analysis of the 309 GDH amino acid sequence, as had been reported in an overseas study, we compared of the amino 310 acid sequence of GDH across the Australian strains (25). We found that all ST1 isolates had amino 311 acid substitutions of A, S, K and K in positions 296, 299, 305 and 330 respectively, the same 312 combination of substitutions reported by Kutz et al. (2008) in highly virulent serotype 2 clones. None 313 of the other Australian STs had this sequence, further demonstrating that virulence may be 314 significantly linked to ST, in this case ST1. 315
Studies have shown that virulent S. suis clones have smaller genome sizes combined with a larger 316 number of virulence genes when compared with less virulent isolates (26). While the sample size of 317 Australian isolates from sites other than the respiratory tract was too small to confirm this, the 318 clustering of ST1 isolates as seen in Figure 2 clearly shows a high number of virulence genes in 319 association with the lowest total gene content of all STs examined. To see if this held true on a global 320 16 scale, we mapped the same data from 443 isolates which clearly demonstrated the same pattern, 321 inclusive of six ST1 single locus variants. A similar pattern, with clustering in the mid genome size and 322 virulence gene range could be seen with ST25 isolates, and again with a larger total gene number in 323 ST28 isolates. This confers with reports suggesting ST28 clones are non-virulent and ST25 clones are 324 of medium virulence (27) in mouse models. This data provides further evidence that ST1 clones 325 worldwide carry high virulence gene content in combination with a low total number of genes and 326 that virulence is more closely associated with MLST than cps type (28). 327
Antimicrobial resistance of Australian strains was similar to levels reported overseas with regards to 328 tetracycline (99.3%), erythromycin (83.8 %) and trimethoprim/sulfamethoxazole (0.7%). Resistance 329 to florfenicol was 14.9%, while all isolates were clinically susceptible to enrofloxacin, likely due to 330 this being banned from use in food producing animals in Australia, and evidence of the success of 331 this programme. Of concern was the observed clinical resistance to penicillin G, albeit at a relatively 332 low level in 8.1% of isolates. This is a first line therapy for S. suis, and indeed the beta-lactams are 333 used in human therapy (29) . Penicillin resistance levels of 5% have been reported in isolates from 334 England (30), and 0% in isolates from China (31). Therefore this is an aspect of S suis in Australia that 335 must be carefully monitored from both an animal and public health point of view. It should also be 336 noted that our analysis did not detect any common beta-lactamase genes, as was the case in a 337 recent study of Spanish and Canadian serotype 9 isolates (32), indicating a potentially unknown 338 mechanism of resistance in these isolates. 339
This study has greatly increased the data available on the circulating strains of S. suis in the 340 Australian pig herd. Comparative genome analysing using Australian and overseas data revealed that 341 production of autogenous vaccine stock should not be based totally on serotype of circulating 342 strains. In fact it is our view that it is equally important to take into account MLST, as we have 343 demonstrated that there is a strong correlation between MLST and virulence gene content. It is 344 possible that the core genome, or specific gene constellations associated with MLST groupings as 345 seen with ST1 isolates in this study, may uncover suitable vaccine targets for development of pan-346 MLST vaccines. Therefore, we recommend that the MLST of isolates from clinical cases be regularly 347 monitored to ensure they match vaccine stocks. With the rapidly expanding range of whole genome 348 sequence analysis pipelines such as that used in this study, clonal typing and virulence marker 349 determination of clones associated with disease outbreaks can be achieved within a matter of days. only one of which was from brain tissue, have diverged significantly from the majority of those 360 studied, and consist predominantly of serotypes 16 and 31, with all except isolate 74-1662 having 361 newly assigned MLSTs. Despite this, it can be seen that for the majority of isolates the core genome 362 has remained consistent with European and North American isolates, such that while Australian 363 clones evolved in isolation, they have continued clustering closely with their hypothesised genetic 364 predecessors. 365
In conclusion, Australian clones associated with disease in pigs consist predominantly of serotypes 2, 366 3 and 1/2, which is consistent with reports from other pig producing countries (8 Whole-genome sequencing. 394 (ThermoFisher Scientific) according to the manufacturer's instructions, with the modification to omit 396 the RNAse treatment step. Library preparation was performed with a Nextera XT kit with the only 397 change from the manufacturer's instructions being an increased tagmentation time of 7 minutes. 398
Sequencing was performed on an Illumina Nextseq 500 platform using a mid-output V2 (2 x 150 399 cycles) reagent kit. 400
Sequence analysis 401
All sequencing files were parsed through the Nullarbor bioinformatics pipeline (v1.20) (35) to 402 determine MLST and antimicrobial resistance genes. A database was manually created containing all 403 capsular serotypes and 40 previously described putative virulence genes (36). The Abricate 404 programme was used to query contig files against the database to determine capsular type and 405 virulence genes, with cutoffs of ≥95% coverage and ≥99% identity used to determine gene presence. 406
Distinguishing serotype 2 from serotype 1/2, and serotype 1 from serotype 14 was performed as 407 outlined by Athey et al. (2016) (37) . 408
Phylogenetic trees were based on single nucleotide polymorphisms in the core genome. For genomic 409 comparison against international S. suis isolates, 383 previously published sequences from 410 Vietnamese, UK, North American and Canadian isolates (26, 38)were downloaded from NCBI and 411 ENA. Genome annotation was performed using Prokka (v1.12) (39) and outputs were processed 412 using Roary (v3.8.0) (40) for core genome determination and Gubbins (v2. 
